Mon, 24th Jun 2019 07:43
(ShareCast News) - OptiBiotix Health's shares dropped on Thursday as the medical product developer reported a wider first half loss. In the six months to the end of May, the loss before tax widened to £713,772 from £514,424 the same period a year earlier as administrative expenses grew to £802,0
Read more(ShareCast News) - AIM-listed OptiBiotix Health said its GoFigure meal replacement shakes and natural snack bars are now available at Whole Foods Market stores in the UK. The life sciences company, which develops compounds to tackle obesity, high cholesterol and diabetes, said GoFigure products will
Read more(ShareCast News) - AIM-listed OptiBiotix Health has announced the appointment of Luis Gosalbez as director of business development with immediate effect. The company, which develops compounds to tackle obesity, high cholesterol, diabetes and skin care, said Gosalbez brings a strong scientific backgr
Read more(ShareCast News) - Obesity, high cholesterol, diabetes and skin care focused life sciences company OptiBiotix Health announced on Tuesday the successful completion of a trial launch for its Slimbiome ingredients in a range of meal replacement shakes and natural snack bars. The AIM-traded firm also r
Read more(ShareCast News) - OptiBiotix had an additional £1m to play with on Friday, announcing a new placing of 1,282,051 ordinary shares at 78p each. The AIM-traded life sciences company, which specialises in products treating obesity, high cholesterol and diabetes, said the placing shares were issued to f
Read more